Compare Onto Innovation (ONTO) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Onto Innovation vs Relay Therapeutics Inc. Common Stock — how do they compare? Onto Innovation trades at $300.11 (market cap $14.94B), while Relay Therapeutics Inc. Common Stock trades at $17.5 (market cap $3.94B). The key difference: Onto Innovation is far larger — about 3.8× Relay Therapeutics Inc. Common Stock's market cap, and Onto Innovation is more actively traded (933,124 versus 3,432,928). Which is the better fit depends on your goals — on Pluang, investors hold Onto Innovation for 5 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| ONTO | RLAY | |
|---|---|---|
Market Cap | $14.94B | $3.94B |
Volume | 933,124 | 3,432,928 |
Sector | Technology | Health |
52-Week High | $378.45 | $20.75 |
52-Week Low | $121.34 | $6.03 |
Typical Hold Time | 5 Days | 0 Days |
Enterprise Value | $14.53B | $3.06B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Onto Innovation
Onto Innovation provides process control solutions for semiconductor manufacturing. Its inspection and metrology systems help chipmakers measure, analyze, and detect defects on wafers and advanced packages.
Read more on ONTO →About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →
